» Articles » PMID: 15168363

Clinical Epidemiology of Inflammatory Bowel Disease: Incidence, Prevalence, and Environmental Influences

Overview
Specialty Gastroenterology
Date 2004 May 29
PMID 15168363
Citations 1064
Authors
Affiliations
Soon will be listed here.
Abstract

Although the incidence and prevalence of ulcerative colitis and Crohn's disease are beginning to stabilize in high-incidence areas such as northern Europe and North America, they continue to rise in low-incidence areas such as southern Europe, Asia, and much of the developing world. As many as 1.4 million persons in the United States and 2.2 million persons in Europe suffer from these diseases. Previously noted racial and ethnic differences seem to be narrowing. Differences in incidence across age, time, and geographic region suggest that environmental factors significantly modify the expression of Crohn's disease and ulcerative colitis. The strongest environmental factors identified are cigarette smoking and appendectomy. Whether other factors such as diet, oral contraceptives, perinatal/childhood infections, or atypical mycobacterial infections play a role in expression of inflammatory bowel disease remains unclear. Additional epidemiologic studies to define better the burden of illness, explore the mechanism of association with environmental factors, and identify new risk factors are needed.

Citing Articles

The Pathogenesis of Inflammatory Bowel Diseases.

Chauhan G, Rieder F Surg Clin North Am. 2025; 105(2):201-215.

PMID: 40015812 PMC: 11868724. DOI: 10.1016/j.suc.2024.10.008.


B-cell Acute Lymphoblastic Leukemia in a Patient With Crohn's Disease After Anti-TNF-Alpha Treatment.

Kawtharani A, Akiki L, Rachid A, Geagea A, Abi Abboud A Cureus. 2025; 17(1):e77400.

PMID: 39949431 PMC: 11822214. DOI: 10.7759/cureus.77400.


Anti-Inflammatory Effects of Algae-Derived Biomolecules in Gut Health: A Review.

Brizzi A, Rispoli R, Autore G, Marzocco S Int J Mol Sci. 2025; 26(3).

PMID: 39940655 PMC: 11817955. DOI: 10.3390/ijms26030885.


The Lived Experience of Adults With Inflammatory Bowel Disease in Rural Areas: Phenomenological Study.

Bosco V, Mercuri C, Doldo P, Nocerino R, Guillari A, Virgolesi M Nurs Health Sci. 2025; 27(1):e70058.

PMID: 39928987 PMC: 11810439. DOI: 10.1111/nhs.70058.


Association Between Genetically Proxied SLC12A2 Inhibition and Inflammatory Bowel Disease: A Mendelian Randomization Study.

Yu X, Cao Y, Mao C, Tao C, Chen W Biochem Genet. 2025; .

PMID: 39913044 DOI: 10.1007/s10528-025-11037-y.